Osteoporosis is the most prevalent metabolic bone disease responsible for a major public health problem. Osteoporosis is mainly characterized by low bone mineral density (BMD). In general, women have lower BMD and higher risk of osteoporosis than men. Most BMD variation is determined by genetic factors with heritability greater than 60%. However, the specific genes involved are largely unknown. Our studies and the studies of others have demonstrated that some osteoporosis risk genes/genomic regions are gender specific. The GOAL of this SCOR is primarily to identify osteoporosis risk genes and their functional aspects in females and, secondarily, to assess the female specificity of these identified genes/functions in male samples. In addition, we will also perform in-depth molecular and cellular functional studies for specific mechanisms and confirmation of the risk genes identified, by studying two novel genes we discovered recently. This SCOR will pioneer a comprehensive and novel approach in bone genetics by investigating osteoporosis at the genome-, transcriptome-, and proteome-wide levels simultaneously. We will use the samples largely recruited or archived for targeted recruitment and adopt state-of-the-art technologies proved successful in our recent pilot studies. This qenomic convergence approach will pinpoint and consolidate the most significant genes identified in each of the individual projects. The genes identified will be subject to replication studies within and across populations by ourselves and our collaborators. All the genes identified in the genomic convergence approach will be subject to in-depth functional studies for confirmation and functional mechanisms as exemplified in Stage 2 of Project 2 of this SCOR. This SCOR is composed of three projects, all aimed at identifying osteoporosis risk genes but from different genomic approaches. Project 1 is to perform a whole genome association scan using dense SNPs to identify those genes/regions that are associated with risk of osteoporosis. Project 2 is to perform a DMA microarray study to scan >40,000 known human genes and ESTs to identify those mRNAs and corresponding genes associated with osteoporosis. Project 3 is to perform proteomics studies to identify those proteins (and corresponding genes) associated with osteoporosis. The SCOR has three cores: A) Administrative Core;B) Clinical Core;and C) Biostatistics and Bioinformatics Core. Each core serves all the three projects. For example, the Clinical Core recruits samples that are shared by Projects 2 and 3;provides support for clinical related issues (such as choice of important medical and environmental factors for co-variate analyses) and for human subject research issues in Project 1. Identifying genes and their functions for human BMD variation, especially for women, is important for 1) gaining insights into the fundamental molecular mechanisms underlying risk of osteoporosis, 2) discovering new pathways and targets for therapeutic cures;3) identifying genetically susceptible individuals, so that future preventions and interventions can be targeted to and based on individuals'specific genotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center (P50)
Project #
3P50AR055081-06S1
Application #
8537002
Study Section
Special Emphasis Panel (ZRG1-HOP-U (40))
Program Officer
Sharrock, William J
Project Start
2007-09-07
Project End
2013-07-31
Budget Start
2012-09-01
Budget End
2013-07-31
Support Year
6
Fiscal Year
2012
Total Cost
$450,000
Indirect Cost
$150,997
Name
Tulane University
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Pei, Yu-Fang; Tian, Qing; Zhang, Lei et al. (2016) Exploring the Major Sources and Extent of Heterogeneity in a Genome-Wide Association Meta-Analysis. Ann Hum Genet 80:113-22
He, H; Liu, Y; Tian, Q et al. (2016) Relationship of sarcopenia and body composition with osteoporosis. Osteoporos Int 27:473-82
Dong, S-S; Guo, Y; Zhu, D-L et al. (2016) Epigenomic elements analyses for promoters identify ESRRG as a new susceptibility gene for obesity-related traits. Int J Obes (Lond) 40:1170-6
Niu, Tianhua; Liu, Ning; Yu, Xun et al. (2016) Identification of IDUA and WNT16 Phosphorylation-Related Non-Synonymous Polymorphisms for Bone Mineral Density in Meta-Analyses of Genome-Wide Association Studies. J Bone Miner Res 31:358-68
He, Hao; Cao, Shaolong; Niu, Tianhua et al. (2016) Network-Based Meta-Analyses of Associations of Multiple Gene Expression Profiles with Bone Mineral Density Variations in Women. PLoS One 11:e0147475
Pei, Yu-Fang; Hu, Wen-Zhu; Hai, Rong et al. (2016) Genome-wide association meta-analyses identified 1q43 and 2q32.2 for hip Ward's triangle areal bone mineral density. Bone 91:1-10
Guo, Yan; Dong, Shan-Shan; Chen, Xiao-Feng et al. (2016) Integrating Epigenomic Elements and GWASs Identifies BDNF Gene Affecting Bone Mineral Density and Osteoporotic Fracture Risk. Sci Rep 6:30558
Zeng, Yong; Zhang, Lan; Zhu, Wei et al. (2016) Quantitative proteomics and integrative network analysis identified novel genes and pathways related to osteoporosis. J Proteomics 142:45-52
Yang, Tie-Lin; Guo, Yan; Zhang, Ji-Gang et al. (2015) Genome-wide Survey of Runs of Homozygosity Identifies Recessive Loci for Bone Mineral Density in Caucasian and Chinese Populations. J Bone Miner Res 30:2119-26
Tan, Li-Jun; Wang, Zhuo-Er; Wu, Ke-Hao et al. (2015) Bivariate Genome-Wide Association Study Implicates ATP6V1G1 as a Novel Pleiotropic Locus Underlying Osteoporosis and Age at Menarche. J Clin Endocrinol Metab 100:E1457-66

Showing the most recent 10 out of 144 publications